Hospital Garcia de Orta

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Deep vein thrombosis and pulmonary embolism2 trials
• Coronary artery disease1 trial
• Epilepsy1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Frontotemporal dementia1 trial
• Gastric and oesophageal cancer1 trial
• Liver and biliary tract cancer1 trial
• Peripheral artery disease1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 35 trials

Status

• Completed5 trials
• Active, not recruiting4 trials
• Suspended1 trial

Lead sponsor

• Assistance Publique - Hôpitaux de Paris1 trial
• Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA1 trial
• CENTOGENE GmbH Rostock1 trial
• Eisai Inc.1 trial
• Hoffmann-La Roche1 trial
• and 5 more

Running trials

• Active, not recruiting

  The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)

  NCT06416644· Hospital do Divino Espírito Santo de Ponta Delgada· Source

• Active, not recruiting

  A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

  NCT05152147· Phase 3· Jazz Pharmaceuticals· Source

• Active, not recruiting

  Pulmonary Embolism International THrOmbolysis Study-3

  NCT04430569· Phase 3· Assistance Publique - Hôpitaux de Paris· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

Closed trials

• Recruiting

  Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  NCT05219617· Phase 3· SK Life Science, Inc.· Source

  Contact: Barbara Remes

• Completed

  Epidemiological Study in FRONtoTemporal Dementia

  NCT05075187· CENTOGENE GmbH Rostock· Source

• Completed

  A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma

  NCT04763408· Eisai Inc.· Source

• Completed

  Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI

  NCT04481997· Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA· Source

• Completed

  A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

  NCT04148911· Phase 3· Hoffmann-La Roche· Source